Meridian Bioscience (VIVO) Delnica Cena

Meridian Bioscience Cena

NASDAQ·ZAPRTO
1,89
​
Trg je zaprt

V zadnjih 19 letih so prihodki Meridian Bioscience rasli 8,9 % letno in dosegli 333,02 Mio. USD. Dobiček na delnico je rasel 8,4 % letno v zadnjih 19 letih. Za Meridian Bioscience je čista marža 12,7 % narasla v primerjavi s 11,1 % pred nekaj leti. Po današnji ceni je dividendna donosnost približno 6,61 %. Izplačilni delež je okoli 22 % dobička.

Cena delnice Meridian Bioscience

Do teh podatkov prek Eulerpool API

100.000 zahtevkov/mes. brezplačno · brez kartice

Meridian Bioscience poslovni model in analiza delnice

Meridian Bioscience Inc. je globalno podjetje, specializirano za razvoj, proizvodnjo in distribucijo diagnostičnih testov za ugotavljanje nalezljivih bolezni ter drugih medicinskih stanj. Podjetje je leta 1976 ustanovil William J. Motto in se sprva osredotočalo na razvoj encimskih imunoloških preskusov (EIA). V letih delovanja se je podjetje razvilo in diversificiralo ponudbo izdelkov, pri čemer postaja vodilni dobavitelj diagnostičnih testov za akutna in kronična medicinska stanja, nalezljive bolezni, črevesne okužbe in virologijo. Uspeh podjetja je posledica širokega spektra testov na različnih medicinskih področjih, vključno z imunologijo, nalezljivimi boleznimi, spolno prenosljivimi boleznimi, gastroenterologijo in virologijo. Poleg tega Meridian Bioscience Inc. sledi najnovejšim tehnološkim napredkom v biotehnologiji, da zagotovi hitro in učinkovito izvajanje svojih testov. Podjetje posluje globalno, sodeluje z univerzami, raziskovalnimi inštituti, vladnimi agencijami in distributerji ter tako zagotavlja svetovno distribucijo in trženje svojih izdelkov. Povzeto, Meridian Bioscience Inc. je inovativno podjetje, specializirano za razvoj, proizvodnjo in distribucijo diagnostičnih testov za ugotavljanje nalezljivih bolezni in drugih medicinskih stanj. Njegov širok nabor izdelkov, vključno z imunološkimi produkti, diagnostiko nalezljivih bolezni, testi za spolno prenosljive bolezni, gastroenterologijo, virologijo in molekularno diagnostiko, skupaj z naprednimi tehnologijami, zagotavlja hiter, natančen in zanesljiv diagnostični nadzor.

Pogosto postavljena vprašanja o delnici Meridian Bioscience

The business model of Meridian Bioscience Inc revolves around manufacturing and distributing diagnostic products for the healthcare industry. With a focus on infectious disease testing, the company provides a range of products including molecular and immunoassay tests, as well as reagents and related equipment. Meridian Bioscience Inc aims to develop innovative solutions for quick and accurate diagnosis, helping healthcare professionals worldwide make informed decisions. Through its expertise and continual investment in research and development, the company strives to improve patient outcomes and contribute to the overall public health. Meridian Bioscience Inc's commitment to quality and customer satisfaction is evident in their comprehensive portfolio of diagnostic solutions.

Meridian Bioscience Inc is primarily active in the healthcare and life sciences industries.

The main competitors of Meridian Bioscience Inc in the market are companies like Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Quidel Corporation, and Bio-Rad Laboratories. These companies operate in the healthcare and diagnostics industry, offering similar products and services. Meridian Bioscience Inc competes based on factors such as product quality, technological advancements, pricing strategy, and customer satisfaction. While Thermo Fisher Scientific is a well-established player in the market, Meridian Bioscience Inc continues to carve its niche through innovative solutions and a strong customer-centric approach.

Meridian Bioscience Inc is a leading life science company that develops and markets a broad range of innovative diagnostic products. Founded in 1976, the company has a rich history and a strong background in developing and commercializing diagnostic tests for various infectious diseases. Meridian Bioscience Inc has evolved over the years and has expanded its product portfolio to cater to the needs of laboratories, hospitals, and other healthcare providers worldwide. With a focus on quality, accuracy, and reliability, the company has garnered a reputation for delivering efficient and effective diagnostic solutions. Meridian Bioscience Inc remains committed to advancing healthcare and improving patient outcomes through its cutting-edge diagnostic technologies and dedication to innovation.

Meridian Bioscience Inc has achieved several significant milestones throughout its history. One notable accomplishment is the company's development and commercialization of innovative diagnostic test kits for various diseases and healthcare conditions. Furthermore, Meridian Bioscience Inc has consistently expanded its product portfolio, introducing novel technologies to improve healthcare outcomes. The company's dedication to research and development has led to the successful launch of multiple FDA-cleared and CE-marked diagnostic tests. Meridian Bioscience Inc's commitment to quality has enabled it to establish a strong presence in the global diagnostics market.

Meridian Bioscience Inc is primarily present in the United States.

Meridian Bioscience Inc represents a strong set of values and corporate philosophy. The company is committed to quality and innovation in the field of biotechnology. They strive to provide accurate and reliable diagnostic solutions to improve patient care. Meridian Bioscience Inc also prioritizes integrity and ethical conduct in all aspects of their business operations. With a focus on customer satisfaction, they aim to exceed expectations and deliver exceptional products and services. As an industry leader, Meridian Bioscience Inc continues to drive advancements in the healthcare sector through their dedication to excellence and integrity.

7 analitikov trenutno ocenjuje delnico Meridian Bioscience: 6 priporoča nakup, 1 držanje in 0 prodajo.

Po trenutnem tečaju se delnica Meridian Bioscience trguje po 1,69 EUR (1,89 USD).

Delnica Meridian Bioscience (VIVO) je uvrščena na 4 borzah, med njimi: NASDAQ (VIVO), London (0K0K.L), Frankfurt (MR4.F), München (MR4.MU).

Meridian Bioscience Inc is a global company specializing in the development, manufacture, and distribution of diagnostic and testing systems for the rapid and accurate identification of infectious diseases. The company was founded in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates several business segments, including diagnostics, OEM, and life science. In the diagnostics segment, the company offers a variety of products for the identification of infectious diseases, including tests for respiratory infections, gastroenteritis, STDs, and Zika virus. Meridian Bioscience's diagnostic products are used in clinical laboratories, hospitals, medical practices, and research laboratories worldwide. The OEM segment of Meridian Bioscience offers customized diagnostic products tailored to the specific requirements of OEM customers. This includes both raw materials and finished products that can be integrated into customers' diagnostic products. The OEM segment of Meridian Bioscience works closely with OEM customers to provide customized, cost-effective, and high-quality products. In the life science segment, Meridian Bioscience offers a wide range of products, including enzymes, antibodies, proteins, buffering solutions, and labeling reagents. These products are used in research and development, diagnostics, and industry. Meridian Bioscience has experienced strong growth in recent years, driven by the introduction of new products, expansion into new markets, and the acquisition of other companies. An example of this is the acquisition of the Bioline Group in 2018, a leading provider of molecular biology products used in research and diagnostics. Meridian Bioscience is committed to developing and manufacturing high-quality products that deliver fast and accurate results. The company works closely with customers and partners to develop innovative products that meet the needs of the healthcare industry. With its wide range of products and commitment to innovation and quality, Meridian Bioscience will continue to play an important role in the diagnostics industry.

Prihodkov za Meridian Bioscience trenutno ni mogoče izračunati.

Dobička za Meridian Bioscience trenutno ni mogoče izračunati.

Razmerja cena-dobiček za Meridian Bioscience trenutno ni mogoče izračunati.

Razmerja cena-prihodki za Meridian Bioscience trenutno ni mogoče izračunati.

Eulerpool ocena kvalitete za Meridian Bioscience je 7/10.

ISIN Meridian Bioscience je US5895841014. ISIN (International Securities Identification Number) je svetovni edinstven identifikator za vrednostne papirje.

WKN Meridian Bioscience je 871583. WKN (Wertpapierkennnummer) je šestmestna nemška oznaka za identifikacijo vrednostnih papirjev.

Ticker Meridian Bioscience je VIVO. Ticker simbol se uporablja za trgovanje z delnicami Meridian Bioscience na borzi.

Poštena vrednostTerminal
1,66 USD
Precenjenost/podcenjenostTerminal
Pošteno ocenjena
Sektor
Industrija
Medicinska oprema in pripomočki
Število delnic
Zaposleni
Prihodki na zaposlenega
504.572,73 USD
Rast prihodkov Ø5 let
Rast EBIT Ø5 let
Rast neto dohodka Ø5 let
Valuta
USD
Javna ponudba delnic
29. jul. 1986
ISIN
US5895841014
CUSIP
589584101
SEDOL
2580265
Tržna kapitalizacija
Razpon 52 tednov
AAQS
7 / 10
PEG
—
P/E razmerje
KGVe 2023
2,25
KGVe 2024
3,20
KGVe 2025
4,47
P/S
KUVe
0,29
EV/EBIT
—
KBV
0,23
ROE (Donosnost kapitala)
ROA (Donosnost sredstev)
ROCE (Donosnost porabljenega kapitala)
ROIC (Donosnost vloženega kapitala)
10,80 %
Zadnja posodobitev 11. nov. 2026, 06:49

Meridian Bioscience Ticker

FRANKFURT · MR4.FLONDON · 0K0K.LMÜNCHEN · MR4.MUNASDAQ · VIVO

Meridian Bioscience FIGI

MR4:GF · BBG000GT3TJ1MR4:GS · BBG000GT4YY2VIVOUSD:XB · BBG00JSL7CZ9VIVOUSD:XS · BBG00JSL7DF9VIVOGBX:B1 · BBG00L2YZQT9